Eisai Co Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 61
- Published: July 2019
- Report Code: MLPH29032FSA
Eisai Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Eisai Co Ltd (Eisai) is a pharmaceutical company that conducts research, development, manufacture and sale of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics. The company’s franchise areas in research include neurology and oncology. Eisai’s major products include Pariet/AcipHex (proton pump inhibitor); Aricept, an anti-Alzheimer's agent; Halaven, a novel anti-cancer agent; Fycompa, an anti-epileptic and peripheral neuropathy treatment, among others. Eisai has production plants in Japan, the UK, China and India and laboratories in Japan, the US and the UK; overseas sales offices in the US, Germany, France, China and South Korea. Eisai is headquartered in Tokyo, Japan.
Scope
Detailed information on Eisai Co Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Eisai Co Ltd in the form of a SWOT analysis
An in-depth view of the business model of Eisai Co Ltd including a breakdown and examination of key business segments
News about Eisai Co Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Eisai Co Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Eisai Co Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Eisai Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Cassava Sciences Inc
Ono Pharmaceutical Co Ltd
Nippon Kayaku Co Ltd
Daiichi Sankyo Inc
Chugai Pharmaceutical Co Ltd
Astellas Pharma Inc
Mochida Pharmaceutical Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.